Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

WAYNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. NASDAQ:AVTX, a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced a late-breaker oral presentation and poster at the…